Resilient Lifescience develops a wearable medical device to prevent opioid overdose deaths using naloxone.
Resilient Lifescience has raised $50K in total funding. The most recent round was Pre-Seed. The last funding was announced in December 2023.
Resilient Lifescience's investors include Tau Ventures, Innovation Works, AlphaLab Health, Richard King Mellon Foundation, Ankit Jain.
Resilient Lifescience is headquartered in Pittsburgh, United States.
Resilient Lifescience develops a wearable medical device to prevent opioid overdose deaths using naloxone.
Resilient Lifescience is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Resilient Lifescience — Funding & Investors." VCBacked, December 6, 2023, https://www.vcbacked.co/company/resilient-lifescience. Accessed October 30, 2026.
VCBacked. (2023). Resilient Lifescience — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/resilient-lifescience
{{cite web |title=Resilient Lifescience — Funding & Investors |url=https://www.vcbacked.co/company/resilient-lifescience |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated